Modification of the metabolic and hormonal response to physical exercise by beta-blocking agents. 1982

M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa

Beta-blockade is known to induce muscle fatigue and tendency to hypoglycaemia during prolonged exercise. In addition, beta-blocking agents influence the secretion of many hormones, which regulate glucose. We have investigated the effects of a beta 1-selective (metoprolol) and a non-selective (propranolol) beta-blocking agent on muscle glycogenolysis, blood glucose and lactate levels, plasma levels of free fatty acids and on secretion of insulin, growth hormone, glucagon and cortisol during physical exercise in a double blind cross-over study in seven healthy male volunteers. They participated in three bicycle ergometer tests each lasting for 30 minutes under treatment of placebo (C), metoprolol (M) or propranolol (P). A biopsy was obtained from the vastus lateralis muscle before and immediately after the exercise for muscle glycogen assay. The glycogen concentration after exercise tended to be lower in C than in M or P experiment. The blood glucose level decreased during P and at 30 min there was a significant difference between P and C. The blood lactate was significantly lower before exercise during P than C or M. The increase of blood lactate during exercise, however, was not inhibited by P. Both beta-blocking agents counteracted the increase of FFA during exercise. There was a marked increase of growth hormone secretion during beta-blockade. The secretion of glucagon and cortisol were slightly increased by P and M, but the plasma insulin level was not affected by beta-blockade.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor

Related Publications

M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
May 1981, Zeitschrift fur Kardiologie,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
April 1985, Drug intelligence & clinical pharmacy,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
May 1969, Australasian annals of medicine,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
January 1974, European journal of applied physiology and occupational physiology,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
February 1969, Canadian journal of physiology and pharmacology,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
December 2008, International journal of sports medicine,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
April 1994, International journal of sports medicine,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
February 1987, Diabetes research (Edinburgh, Scotland),
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
December 1986, The Journal of pharmacology and experimental therapeutics,
M Uusitupa, and O Siitonen, and M Härkönen, and A Gordin, and A Aro, and K Hersio, and G Johansson, and T Korhonen, and R Rauramaa
September 1974, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!